CNS DRUG PROGRESS

Roderick Wong, MD, serves as Managing Partner and Chief Investment Officer of RTW. Rod is responsible for managing the firm’s investments focused on innovative drug development. Prior to forming RTW, he was a Managing Director and sole Portfolio Manager for the Davidson Kempner Healthcare Funds. Before joining Davidson Kempner, Rod held various healthcare investment and research roles at Sigma Capital Partners and Cowen & Company.

Rod simultaneously received an MD from the University of Pennsylvania Medical School and an MBA from Harvard Business School, and graduated Phi Beta Kappa with a BS in Economics from Duke University.

Rod has a keen interest in educating the next generation of life science entrepreneurs. He regularly sits on a variety of corporate boards. In addition, he serves as an Adjunct Associate Professor of Finance at NYU Stern and as an Advisor to the University of Pennsylvania Medical School’s PennHealthX Program. Rod also serves as Chairman of the RTW Charitable Foundation.

Rod has a keen interest in educating the next generation of life science entrepreneurs. He regularly sits on a variety of corporate boards. In addition, he serves as an Adjunct Associate

Leave a Comment

Your email address will not be published. Required fields are marked *

Access our Annual Results 2019 Presentation Recording

  • This field is for validation purposes and should be left unchanged.